BPG is committed to discovery and dissemination of knowledge
Case Control Study
©The Author(s) 2017.
World J Gastroenterol. Sep 28, 2017; 23(36): 6674-6684
Published online Sep 28, 2017. doi: 10.3748/wjg.v23.i36.6674
Table 2 Distribution of gene polymorphisms in patients with hepatocellular carcinoma, in hepatitis B/hepatitis C -positive patients, and in healthy controls n (%)
GeneSNPGenotypeHCC groupHBV/HCV groupHealthy group
ERCC1rs3212986GG126 (67.7)82 (49.1)91 (47.4)
GT44 (23.7)78 (46.7)81 (42.2)
TT16 (8.6)7 (4.2)20 (10.4)
XRCC3rs1799794AA128 (66.7)108 (65.1)137 (71.7)
AG52 (27.1)55 (33.1)49 (25.7)
GG12 (6.3)3 (1.8)5 (2.6)
GST-P1rs1138272CC172 (92.5)139 (83.2)182 (94.8)
CT13 (7.0)27 (16.2)10 (5.2)
TT1 (0.5)1 (0.6)0 (0.0)
CYP17A1rs743572TT72 (38.1)39 (23.4)54 (28.4)
TC84 (44.4)88 (52.7)91 (47.9)
CC33 (17.5)40 (24.0)45 (23.7)
ABCB1rs1128503CC54 (28.1)52 (31.1)58 (30.2)
CT92 (47.9)93 (55.7)95 (49.5)
TT46 (24.0)22 (13.2)39 (20.3)


Write to the Help Desk